Green Cross Medical Science Corporation Market Cap ($42.95 Million)
Market Cap & Net Worth: Green Cross Medical Science Corporation (142280)
Green Cross Medical Science Corporation market cap. Green Cross Medical Science Corporation (KQ:142280) has a market capitalization of $42.95 Million (₩63.38 Billion) as of November 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22274 globally and #1414 in its home market, demonstrating a -11.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross Medical Science Corporation's stock price ₩2915.00 by its total outstanding shares 21741926 (21.74 Million). Also see Green Cross Medical Science Corporation cash flow conversion for how efficiently the company converts equity into cash flow.
Green Cross Medical Science Corporation Market Cap History (2015–2026)
Green Cross Medical Science Corporation market cap history from 2015 to 2026. Data shows change from $173.24 Million to $42.95 Million (-12.47% CAGR). Check Green Cross Medical Science Corporation (142280) stock price for real-time trading data and today's change.
Index Memberships
Green Cross Medical Science Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$207.23 Billion | 0.02% | #675 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$207.23 Billion | 0.02% | #675 of 1384 |
Weight: Green Cross Medical Science Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Green Cross Medical Science Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Green Cross Medical Science Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Green Cross Medical Science Corporation (142280) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Green Cross Medical Science Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Green Cross Medical Science Corporation's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $132.66 Million | $86.16 Billion | -$1.89 Billion | 0.00x | N/A |
| 2017 | $143.56 Million | $98.39 Billion | -$1.35 Billion | 0.00x | N/A |
| 2018 | $150.22 Million | $86.32 Billion | -$10.71 Billion | 0.00x | N/A |
| 2019 | $77.35 Million | $94.09 Billion | -$16.20 Billion | 0.00x | N/A |
| 2020 | $231.33 Million | $113.38 Billion | $6.72 Billion | 0.00x | 0.03x |
| 2021 | $106.53 Million | $101.67 Billion | -$21.20 Billion | 0.00x | N/A |
| 2022 | $85.16 Million | $113.11 Billion | -$3.58 Billion | 0.00x | N/A |
| 2023 | $70.28 Million | $94.01 Billion | $1.80 Billion | 0.00x | 0.04x |
| 2024 | $52.75 Million | $103.85 Billion | $3.58 Billion | 0.00x | 0.01x |
| 2025 | $59.01 Million | $108.41 Billion | $3.67 Billion | 0.00x | 0.02x |
Competitor Companies of 142280 by Market Capitalization
Companies near Green Cross Medical Science Corporation in the global market cap rankings as of November 5, 2026. Also see Green Cross Medical Science Corporation balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Green Cross Medical Science Corporation by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Green Cross Medical Science Corporation (2015–2026)
Market capitalization of Green Cross Medical Science Corporation from 2015 to today. Between 2015 and today, Green Cross Medical Science Corporation's market cap moved from $173.24 Million to $ 42.95 Million, with a yearly change of -12.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩42.95 Million | -27.22% |
| 2025 | ₩59.01 Million | +11.87% |
| 2024 | ₩52.75 Million | -24.95% |
| 2023 | ₩70.28 Million | -17.47% |
| 2022 | ₩85.16 Million | -20.06% |
| 2021 | ₩106.53 Million | -53.95% |
| 2020 | ₩231.33 Million | +199.05% |
| 2019 | ₩77.35 Million | -48.51% |
| 2018 | ₩150.22 Million | +4.64% |
| 2017 | ₩143.56 Million | +8.22% |
| 2016 | ₩132.66 Million | -23.43% |
| 2015 | ₩173.24 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Green Cross Medical Science Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.95 Million USD |
| MoneyControl | $42.95 Million USD |
| MarketWatch | $42.95 Million USD |
| marketcap.company | $42.95 Million USD |
| Reuters | $42.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Green Cross Medical Science Corporation
GC Medical Science Corporation operates as a diagnostic medical device company in the vitro diagnostic industry in South Korea and internationally. The company's products include human healthcare products for the diagnosis of diabetes, non-communicable diseases, respiratory diseases, and vector borne diseases. It offers CERA-CHEK 1Code and CERA-CHEK 1070 for diabetes; GREENCARE A1c for HbA1c, CER… Read more